399 related articles for article (PubMed ID: 18637123)
1. Multiple myeloma--an update on diagnosis and treatment.
Caers J; Vande broek I; De Raeve H; Michaux L; Trullemans F; Schots R; Van Camp B; Vanderkerken K
Eur J Haematol; 2008 Nov; 81(5):329-43. PubMed ID: 18637123
[TBL] [Abstract][Full Text] [Related]
2. Using genomics to identify high-risk myeloma after autologous stem cell transplantation.
Shaughnessy JD; Barlogie B
Biol Blood Marrow Transplant; 2006 Jan; 12(1 Suppl 1):77-80. PubMed ID: 16399589
[TBL] [Abstract][Full Text] [Related]
3. Conventional therapy and approach to management.
Rajkumar SV; Kyle RA
Best Pract Res Clin Haematol; 2005; 18(4):585-601. PubMed ID: 16026739
[TBL] [Abstract][Full Text] [Related]
4. [Modern treatment methods for multiple myeloma: guidelines from the Dutch Haemato-Oncology Association (HOVON)].
Lokhorst H; Huijgens PC; Raymakers R; Bos GM; Vellenga E; Wijermans PW; Sonneveld P;
Ned Tijdschr Geneeskd; 2005 Apr; 149(15):808-13. PubMed ID: 15850271
[TBL] [Abstract][Full Text] [Related]
5. Multiple myeloma.
Singhal S; Mehta J
Clin J Am Soc Nephrol; 2006 Nov; 1(6):1322-30. PubMed ID: 17699365
[TBL] [Abstract][Full Text] [Related]
6. The evolution and impact of therapy in multiple myeloma.
Laubach JP; Richardson PG; Anderson KC
Med Oncol; 2010 Jun; 27 Suppl 1():S1-6. PubMed ID: 20169425
[TBL] [Abstract][Full Text] [Related]
7. Combinations of cytogenetics and international scoring system can predict poor prognosis in multiple myeloma after high-dose chemotherapy and autologous stem cell transplantation.
Inamoto Y; Kurahashi S; Imahashi N; Fukushima N; Adachi T; Kinoshita T; Tsushita K; Miyamura K; Naoe T; Sugiura I
Am J Hematol; 2009 May; 84(5):283-6. PubMed ID: 19338045
[TBL] [Abstract][Full Text] [Related]
8. Targeted treatments to improve stem cell outcome: old and new drugs.
Raab MS; Breitkreutz I; Anderson KC
Bone Marrow Transplant; 2007 Dec; 40(12):1129-37. PubMed ID: 17768392
[TBL] [Abstract][Full Text] [Related]
9. Multiple myeloma: diagnosis and treatment.
Nau KC; Lewis WD
Am Fam Physician; 2008 Oct; 78(7):853-9. PubMed ID: 18841734
[TBL] [Abstract][Full Text] [Related]
10. Retrospective comparison of bortezomib-containing regimens with vincristine-doxorubicin-dexamethasone (VAD) as induction treatment prior to autologous stem cell transplantation for multiple myeloma.
Eom HS; Min CK; Cho BS; Lee S; Lee JW; Min WS; Kim CC; Kim M; Kim Y
Jpn J Clin Oncol; 2009 Jul; 39(7):449-55. PubMed ID: 19487425
[TBL] [Abstract][Full Text] [Related]
11. Treatment of multiple myeloma in the targeted therapy era.
Saad AA; Sharma M; Higa GM
Ann Pharmacother; 2009 Feb; 43(2):329-38. PubMed ID: 19193585
[TBL] [Abstract][Full Text] [Related]
12. High-dose chemotherapy and autologous hematopoietic stem cell transplantation in myeloma patients under the age of 65 years.
Mehta J; Singhal S
Bone Marrow Transplant; 2007 Dec; 40(12):1101-14. PubMed ID: 17680020
[TBL] [Abstract][Full Text] [Related]
13. Multiple myeloma: charging toward a bright future.
Katzel JA; Hari P; Vesole DH
CA Cancer J Clin; 2007; 57(5):301-18. PubMed ID: 17855486
[TBL] [Abstract][Full Text] [Related]
14. Role of stem cell transplantation.
Harousseau JL
Hematol Oncol Clin North Am; 2007 Dec; 21(6):1157-74, x. PubMed ID: 17996593
[TBL] [Abstract][Full Text] [Related]
15. Presentation and risk stratification--improving prognosis for patients with multiple myeloma.
Lonial S
Cancer Treat Rev; 2010 May; 36 Suppl 2():S12-7. PubMed ID: 20472183
[TBL] [Abstract][Full Text] [Related]
16. Stem-cell transplantation for multiple myeloma in the era of novel drugs.
Bensinger W
J Clin Oncol; 2008 Jan; 26(3):480-92. PubMed ID: 18056678
[TBL] [Abstract][Full Text] [Related]
17. Role of autologous stem-cell transplantation in multiple myeloma.
Attal M; Harousseau JL
Best Pract Res Clin Haematol; 2007 Dec; 20(4):747-59. PubMed ID: 18070717
[TBL] [Abstract][Full Text] [Related]
18. The evolving background for high-dose treatment for myeloma.
Sirohi B; Powles R; Harousseau JL; Anderson KC
Bone Marrow Transplant; 2007 Dec; 40(12):1097-100. PubMed ID: 17906702
[TBL] [Abstract][Full Text] [Related]
19. [Multiple myeloma--new therapeutic perspectives].
Skotnicki AB; Wolska-Smoleń T; Jurczyszyn A
Przegl Lek; 1999; 56 Suppl 1():67-72. PubMed ID: 10494186
[TBL] [Abstract][Full Text] [Related]
20. An update: health economics of managing multiple myeloma.
Moeremans K; Annemans L
Eur J Cancer; 2006 Jul; 42(11):1684-91. PubMed ID: 16781867
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
